Rosenberg (BSBA 1997) was appointed Chief Financial Officer at BeiGene, a global oncology company discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. Rosenberg is a global finance executive with more than 20 years
1997 Articles: page 1
Page:
Page: